Gust Bardy
Hillrom to complete $367M acquisition of Bardy Diagnostics after Delaware judge orders deal to proceed
Hillrom will proceed with its previously announced $367 million acquisition of Seattle startup Bardy Diagnostics after a Delaware judge ordered the deal to close following a dispute over sharp Medicare reimbursement cuts that briefly led Hillrom to try to withdraw.
Hillrom to Buy Bardy Diagnostics for $375M, Deal to Close in Q2 with Possible Milestone Payments
Hillrom will acquire Seattle-based Bardy Diagnostics for $375 million, adding Bardy’s week-long CAM cardiac monitor and related cardiology products to its portfolio; the deal may include future milestone payments and is expected to close in Q2. Bardy, founded in 2013, has about $30 million in annualized revenue, over $20 million in net operating losses, roughly 230 employees, and has raised more than $71 million to date.
Qumulo Adds Ex-Tableau CMO Elissa Fink to Board After $125M Raise; Maven COO Co-founder Bill Sornsin Steps Down
Seattle data-storage startup Qumulo added former Tableau CMO Elissa Fink to its board after raising $125 million and reaching a $1.2B+ valuation; separately, Maven COO and co-founder Bill Sornsin stepped down as part of a company realignment.
See all 4 stories, episodes and videos about Gust Bardy.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
-
Bardy Diagnostics Executive Officer, Director, Promoter 2018, Founder · past